drugset / Trial / NCT04210973
Comparison of Anyu Peibo With Placebo in Treatment of MDD in China
Phase 3
Unknown
266 enrolled
Shanghai Mental Health Center
Su Zhou YiHua Biotechnology Co. LTD · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Anyu Peibo Capsule comparing with placebo in the treatment of Chinese Patients with Depression.
Timeline
- Start
- 2020-01-23
- Primary completion
- 2020-12
- Completion
- 2021-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anyu Peibo | Unknown | 0.8 g | Oral |